Clinical Trial Update: Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 dose-ranging study evaluating sublingual immunotherapy tablets containing house dust mite allergen extracts in adults with dust m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• House Dust Mite Allergy

Drugs mentioned

• HDM SLIT tablet (House dust mite allergen extract sublingual immunotherapy tablet)

Snippet

Sponsor: Stallergenes Greer | Conditions: Asthma, House Dust Mite Allergy | Phase 2 | Status: COMPLETED